Financhill
Back

Blueprint Medicines Stock Predictions

Slow Market? Try This Instead

See how it works now.
Sell
50

BPMC
Blueprint Medicines

Last Price:
$128.39
Seasonality Move:
6.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Your Summer Trading Shortcut

Try it free today.

Blueprint Medicines Stock Forecast

  • Over the next 52 weeks, Blueprint Medicines has on average historically risen by 26.4% based on the past 10 years of stock performance.
  • Blueprint Medicines has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
  • Is Blueprint Medicines Stock Undervalued?
    The current Blueprint Medicines [BPMC] share price is $128.35. The Score for BPMC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Blueprint Medicines Stock Go Up Next Year?

  • Over the next 52 weeks, Blueprint Medicines has on average historically risen by 26.4% based on the past 10 years of stock performance.

Blueprint Medicines Stock Rating

Sell
50
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines overpriced?

  • Blueprint Medicines has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%

Blueprint Medicines Stock Price History

Is BPMC stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
blueprintmedicines.com

52-Week Data

52-Week High:
128.52
52-Week Low:
73.04

Prediction Charts

Market Cap:
8.3B
Price in USD:
128.35
Volume:
1.4M
Beta:
0.99

Technical Analysis

SMA50:
111.57
SMA100:
100.78
SMA200:
97.60
52-Wk Change:
17.72%

Stock Predictions

  • Is Blueprint Medicines stock public?
    Yes, Blueprint Medicines is a publicly traded company.
  • What is the Blueprint Medicines stock quote today?
    The Blueprint Medicines stock price is 128.35 USD today.
  • How to buy Blueprint Medicines stock online?
    You can buy Blueprint Medicines shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-13 128.18 127.96 128.27 127.95
Jun-16 128.05 128.25 128.30 127.86
Jun-17 128.14 128.23 128.33 128.03
Jun-18 128.29 128.12 128.32 128.02
Jun-20 128.27 128.20 128.30 128.00
Jun-23 128.19 128.40 128.45 128.11
Jun-24 128.40 128.26 128.40 128.15
Jun-25 128.30 128.25 128.32 128.19
Jun-26 128.29 128.15 128.31 128.10
Jun-27 128.24 128.11 128.28 128.06
Jun-30 128.30 128.18 128.32 128.08
Jul-1 128.18 128.34 128.52 128.16
Jul-2 128.35 128.20 128.45 128.20
Jul-3 128.25 128.35 128.40 128.20

Blueprint Medicines Earnings

Blueprint Medicines Earnings Report: Per Share Blueprint Medicines Earnings Q1 Q2 Q3 and Q4 last year and next year.

Blueprint Medicines Forecast Revenue Growth

Blueprint Medicines Stock Analysis: Historical quarterly revenues per share for Blueprint Medicines and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.

* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.